课题基金 / 基金详情

Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart

Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart
缺血心脏中同种异体间充质干细胞免疫原性的决定因素
批准号:
478259
负责人:
Dhingra Sanjiv
金额:
$74.87万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2028-03-01

项目摘要

项目成果

Dhingra Sanjiv的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Stem cells-based therapies are considered a novel option for the treatment of different disease conditions including heart disease. Stem cells have the ability to repair the heart after an injury due to heart attack. Bone marrow derived mesenchymal stem c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of COP 9 signalosome subunit 5 in preserving immunoprivilege of allogeneic mesenchymal stem cells in the ischemic heart
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
Preserving the immunoprivilege of transplanted allogeneic mesenchymal stem cells in the ischemic heart
海外基金